Empagliflozin/Metformin fixed-dose combination tablet 12.5 mg/500 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Empagliflozin/Metformin fixed-dose combination tablet 12.5 mg/500 mg, covering 2016-11-30 to 2016-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions [Phase 1]